Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
Interaction of mycobacteria with Plasmin(ogen) affects phagocytosis and granuloma development
Gabriela Echeverría-Valencia1, Mayra Silva-Miranda2, Euloge Ekaza3
1Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Apartado Postal 70-228, México D.F, 04510, Mexico.
Abstract:
Plasminogen and plasmin are fundamental components of the fibrinolytic system that interact with microorganisms generating different immunopathological effects. The molecules of Mycobacterium tuberculosis interplaying with plasminogen have already been identified and characterized. In this work, we studied the effects of plasmin(ogen) bound toMycobacterium bovisCalmette-Guérin (BCG) on phagocytosis in THP1 macrophages as well as in granuloma formation and development on in vitrohuman granuloma model. For this purpose, BCG was coated with plasminogen and plasmin, obtained after activation of zymogen by tissue plasminogen activator. The results showed a significant reduction in the number of bacteria phagocytosed by macrophages in presence of plasminogen or plasmin on BCG surface. On the other hand, at 3 days BCG/plasminogen/plasmin induced an increase granuloma numbers with respect to those induced by uncoated bacteria. BCG/plasminogen/environments also showed a significant increase of IL-6 secretion. At 7 days, a reduced number of granulomas and an increased number of bacteria was observed with respect to uncoated BCG environment. Altogether, these results showed that plasmin(ogen) on the mycobacterial surface affects phagocytosis, granuloma development and the cytokine context, thus resulting in an increased number of bacteria in granulomas.
Insights
Mycobacterium bovis BCG coated with plasminogen or plasmin reduced macrophage phagocytosis but initially increased granuloma formation. Ultimately, plasmin(ogen) on BCG led to more bacteria within granulomas.
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Plasminogen and plasmin are key fibrinolytic system components with immunopathological roles.
- Mycobacterium tuberculosis interactions with plasminogen are known, but effects on Mycobacterium bovis BCG are less understood.
Purpose of the Study:
- To investigate the impact of plasminogen/plasmin bound to Mycobacterium bovis BCG on macrophage phagocytosis and in vitro human granuloma formation.
- To determine how BCG-bound plasminogen/plasmin influences cytokine secretion and bacterial load within granulomas.
Main Methods:
- Coating Mycobacterium bovis BCG with plasminogen and plasmin (activated by tissue plasminogen activator).
- Assessing phagocytosis by THP1 macrophages.
- Evaluating granuloma formation, development, and bacterial presence in an in vitro human granuloma model.
- Measuring Interleukin-6 (IL-6) secretion.
Main Results:
- BCG coated with plasminogen or plasmin showed significantly reduced phagocytosis by macrophages.
- At 3 days, BCG with plasminogen/plasmin increased granuloma numbers and IL-6 secretion compared to uncoated BCG.
- By 7 days, fewer granulomas and more bacteria were observed with BCG/plasminogen/plasmin compared to uncoated BCG.
Conclusions:
- Plasminogen/plasmin on the mycobacterial surface modulates macrophage phagocytosis.
- BCG-bound plasminogen/plasmin influences granuloma development and the cytokine environment.
- These interactions ultimately lead to an increased bacterial burden within granulomas, suggesting a role in mycobacterial pathogenesis.
Related Concept Videos
Phagocytosis
Phagocytosis
The objective of phagocytosis is often destruction. Cells use phagocytosis to eliminate unwelcome visitors, like pathogens (e.g., viruses and bacteria). Many immune system cells,...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Sustainable Development
Predator-Prey Interactions
piRNA - Piwi-interacting RNAs

